Lifeline Biotechnologies
(OTC) LLBO
Lifeline Biotechnologies Financials at a Glance
Market Cap
$2.61M
Revenue (TTM)
$0.00
Net Income (TTM)
$61.86K
EPS (TTM)
$0.00
P/E Ratio
0.00
Dividend
$0.00
Beta (Volatility)
-120.35 (Low)
Dividend
$0.00
Beta (Volatility)
-120.35 (Low)
Price
$0.00
Volume
50,000
Open
$0.00
Price
$0.00
Volume
50,000
Open
$0.00
Previous Close
$0.00
Daily Range
$0.00 - $0.00
52-Week Range
$0.00 - $0.00
Dividend
$0.00
Beta (Volatility)
-120.35 (Low)
Price
$0.00
Volume
50,000
Open
$0.00
Previous Close
$0.00
Daily Range
$0.00 - $0.00
52-Week Range
$0.00 - $0.00
LLBO News
LLBO: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Lifeline Biotechnologies
Industry
Healthcare Equipment and Supplies
Sector
Health CareEmployees
1
CEO
James D. Holmes, MBA
Website
www.lbti.comHeadquarters
Reno, NV 89502, US
LLBO Financials
Key Financial Metrics (TTM)
Gross Margin
0%
Operating Margin
0%
Net Income Margin
0%
Return on Equity
0%
Return on Capital
0%
Return on Assets
0%
Earnings Yield
N/A
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$2.61M
Shares Outstanding
4.35B
Volume
50.00K
Short Interest
0.00%
Avg. Volume
1.29M
Financials (TTM)
Gross Profit
$0.00
Operating Income
$5.80K
EBITDA
$5.80K
Operating Cash Flow
$139.82K
Capital Expenditure
$0.00
Free Cash Flow
$139.82K
Cash & ST Invst.
$415.00
Total Debt
$327.12K
Lifeline Biotechnologies Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonCurrently no data to display.
Earnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonCurrently no data to display.
Quarterly Performance
Revenue
$0.00
N/A
Gross Profit
$0.00
N/A
Gross Margin
0.00%
N/A
Market Cap
$2.61M
N/A
Market Cap/Employee
N/A
N/A
Employees
N/A
N/A
Net Income
$30.09K
-2908.6%
EBITDA
$30.09K
-2908.6%
Quarterly Fundamentals
Net Cash
N/A
N/A
Accounts Receivable
N/A
N/A
Inventory
N/A
N/A
Long Term Debt
N/A
N/A
Short Term Debt
N/A
N/A
Return on Assets
0.00%
N/A
Return on Invested Capital
0.00%
N/A
Free Cash Flow
N/A
N/A
Operating Cash Flow
N/A
N/A